437 studies found for:    "neuroblastoma"
Show Display Options
Rank Status Study
21 Completed Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: melphalan;   Drug: tretinoin;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous bone marrow transplantation;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
22 Active, not recruiting Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
Condition: Neuroblastoma
Interventions: Genetic: gene mapping;   Genetic: polymorphism analysis
23 Active, not recruiting Protein Expression in Human Neuroblastoma Tumor Samples
Condition: Neuroblastoma
Interventions: Genetic: protein expression analysis;   Genetic: western blotting;   Other: laboratory biomarker analysis
24 Active, not recruiting Biomarkers in Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: DNA analysis;   Genetic: DNA methylation analysis;   Genetic: RNA analysis;   Genetic: comparative genomic hybridization;   Genetic: mutation analysis;   Genetic: polymorphism analysis
25 Active, not recruiting Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: DNA analysis;   Genetic: polymerase chain reaction;   Other: laboratory biomarker analysis;   Other: medical chart review
26 Active, not recruiting Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: RNA analysis;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Genetic: proteomic profiling;   Genetic: western blotting;   Other: enzyme-linked immunosorbent assay;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: liquid chromatography;   Other: mass spectrometry
27 Active, not recruiting Studying Gene Expression in Samples From Younger Patients With Neuroblastoma
Conditions: Neoplastic Syndrome;   Neuroblastoma
Interventions: Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: enzyme-linked immunosorbent assay;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: medical chart review
28 Recruiting Phase II Study of Proton Radiation Therapy for Neuroblastoma
Conditions: Neuroblastoma;   Ganglioneuroblastoma
Intervention: Radiation: Proton Beam Radiation Therapy
29 Active, not recruiting Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: RNA analysis;   Genetic: gene expression analysis;   Other: laboratory biomarker analysis
30 Unknown  Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: melphalan;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
31 Unknown  Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
32 Active, not recruiting Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Intervention: Biological: anti-GD2 murine IgG3 monoclonal antibody 3F8
33 Unknown  Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Biological: monoclonal antibody Ch14.18;   Drug: busulfan;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: isotretinoin;   Drug: melphalan;   Drug: vincristine sulfate;   Procedure: bone marrow ablation with stem cell support;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
34 Completed Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: melphalan;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation
35 Completed Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: monoclonal antibody 3F8;   Drug: etoposide;   Drug: isotretinoin
36 Unknown  Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
37 Completed Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: melphalan;   Drug: mesna;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous bone marrow transplantation;   Procedure: conventional surgery;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET electron therapy;   Radiation: low-LET photon therapy;   Radiation: radioisotope therapy
38 Completed Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Kidney Cancer;   Liver Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma
Intervention: Drug: arsenic trioxide
39 Active, not recruiting Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: topotecan hydrochloride;   Drug: Isotretinoin
40 Completed Combination Chemotherapy in Treating Children With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years